Clinical study of hydrogen inhalation in the treatment of herpes zoster neuralgia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067888

Enrollment

Unknown

Registered

2023-01-30

Start date

2023-02-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster neuralgia

Interventions

Hydrogen suction group:Hydrogen inhalation based on routine treatment

Control group:conventional therapy

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of herpes zoster neuralgia is clear; 2. Stable control of complications; 3. Cooperate and agree to enter the clinical study.

Exclusion criteria

Exclusion criteria: 1. Severe cardiac, hepatic and renal insufficiency; 2. History of co-infection, malignant tumor; 3. With psychiatric system diseases that cannot cooperate with treatment and unclear articulation; 4. Suffering from respiratory system diseases, respiratory insufficiency.

Design outcomes

Primary

Measure	Time frame
NRS, numerical rating scale;Inflammatory factors;	—

Countries

China

Contacts

Public ContactWu Xue

Taian Central Hospital

tazxwx@163.com+86 18265384195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026